Rosuvastatin calcium 5 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB26FJRWH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,200
Award facts
- Contract value 100% obligated
- $1,200.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,200 to DMS Pharmaceutical Group Inc. on October 27, 2025, for the supply of Rosuvastatin Calcium 5 mg tablets (90-count). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price delivery order with no set-aside designation. The ultimate completion date for this delivery order is October 28, 2025, with performance to occur at the contractor's facility in Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's PPV-G GEN V contract, valued at $499,999,999 and effective through December 31, 2036, authorizes the Defense Logistics Agency to issue delivery orders for branded and generic prescription drugs, biologics, vaccines, over-the-counter medications, and medical consumables. The company's substantial prior delivery order activity with the Defense Logistics Agency demonstrates its established capability to support recurring pharmaceutical supply requirements across the military healthcare system.
Quick answers
Who was awarded contract SPE2DB26FJRWH?
SPE2DB26FJRWH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FJRWH worth?
The government has obligated $1,200 on SPE2DB26FJRWH.
Is contract SPE2DB26FJRWH an order under another contract?
Yes. SPE2DB26FJRWH is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWH competed?
The extent of competition for SPE2DB26FJRWH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award